Dr. Verstraete is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1825 4th St
San Francisco, CA 94143Phone+1 415-353-2813Fax+1 415-353-2474
Education & Training
- University of California (San Francisco)Fellowship, Pediatric Gastroenterology, 2012 - 2016
- University of California (San Francisco)Fellowship, Pediatric Gastroenterology, 2016
- University of Miami/Jackson Health SystemResidency, Pediatrics, 2009 - 2012
- Universidad Nacional Autonoma de MexicoClass of 2008
Certifications & Licensure
- CA State Medical License 2012 - 2025
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Gastroenterology
Clinical Trials
- Personalized AZithromycin/metronidAZole Therapy in Pediatric Crohn's Disease (CD) Start of enrollment: 2021 Aug 13
- A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Ulcerative Colitis (UC) Start of enrollment: 2022 Apr 18
Roles: Principal Investigator
- A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD) Start of enrollment: 2022 Apr 30
Roles: Principal Investigator
- Join now to see all
Publications & Presentations
PubMed
- 70 citationsEnteric Virome and Bacterial Microbiota in Children With Ulcerative Colitis and Crohn Disease.Melissa A. Fernandes, Sofia G. Verstraete, Tung Gia Phan, Xutao Deng, Emily Stekol
Journal of Pediatric Gastroenterology and Nutrition. 2019-01-01 - 15 citationsEndpoints for extraintestinal manifestations in inflammatory bowel disease trials: the EXTRA consensus from the International Organization for the Study of Inflammator...Lucas Guillo, Maria Abreu, Remo Panaccione, William J Sandborn, Valderilio F Azevedo
The Lancet. Gastroenterology & Hepatology. 2022-03-01 - 12 citationsExperience Using Ustekinumab in Pediatric Patients With Medically Refractory Crohn Disease.Francis Kim, Perseus V Patel, Emily Stekol, Sabina Ali, Hassan Hamandi
Journal of Pediatric Gastroenterology and Nutrition. 2021-07-09
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: